Navigation Links
Takeda to Create Global Centers of Excellence
Date:3/30/2009

Reorganization helps Takeda realize globalization vision

OSAKA, Japan, March 30 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") today announced a reorganization of its corporate structure, as part of its 2006-2010 Medium-Term Plan vision to become a global pharmaceutical company with highly integrated global operations. In order to become more responsive to rapid changes in the global operating environment and to maximize the global market potential of new products and the company's global presence, the company is streamlining executive reporting relationships to Yasuchika Hasegawa, President, by creating corporate-level, center of excellence R&D, commercial and administrative functions. Effective April 1, 2009, Shigenori Ohkawa, Ph.D., will become Chief Scientific Officer (CSO), and Alan MacKenzie will become Executive Vice President (EVP) International Operations. Additionally, a Chief Administrative Officer (CAO) role will be established.

"Takeda is making meaningful changes in structure and governance through this reorganization and the creation of the CSO, EVP, International Operations, and CAO roles, which we believe will further strengthen our global operations structure," said Yasuchika Hasegawa, President, Takeda Pharmaceutical Company Limited. "Through this new organizational structure, Takeda looks forward to continuing our history of creating and marketing novel pharmaceutical products that meet the needs of patients globally."

Details of the Reorganization

Effective April 1, 2009, Shigenori Ohkawa, Ph.D., will assume the role of Chief Scientific Officer, responsible for global Research, Development, Chemistry Manufacturing and Controls (CMC), and Intellectual Property (IP). The creation of the CSO role provides the opportunity to further enhance product development effectiveness through the integration of research and development. The
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Takeda Receives New Information on Alogliptin (SYR-322) NDA
2. Healthcare Businesswomens Association Announces 2009 Woman of the Year, Dr. Deborah Dunsire, President and CEO of Millennium: The Takeda Oncology Company
3. Welvista Announces Partnering with Takeda to Provide Medication at No Cost to the Uninsured
4. Review of Takedas Febuxostat New Drug Application Continues Past PDUFA Date
5. FDA Adds Three Months to Review of Takedas New Drug Application for TAK-390MR
6. Takedas investigational PPI TAK-390MR demonstrated higher healing rates compared to lansoprazole
7. Takeda Completes Acquisition of Millennium
8. Takeda Commences Cash Tender Offer for all Outstanding Shares of Millennium
9. Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
10. Takeda Announces New U.S. Leadership
11. Takeda submits new drug application for alogliptin (syr-322) in the US
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Obispo, CA (PRWEB) August 21, 2014 ... of Current Pedorthics, a bi-monthly publication of the Pedorthic Footcare ... of pedorthics. , Bunion Bootie is ... alternative solution for bunion sufferers and their pain. It is ... in nearly any shoe to eliminate the friction and rubbing ...
(Date:8/21/2014)... August 21, 2014 According to a ... of Ophthalmology, environmental factors may outweigh genetics in the development ... percent of the world’s population is nearsighted, and this study ... , “This is an important finding in the field of ... only are we finding better ways to treat ophthalmological ...
(Date:8/21/2014)... Hills Medical Center of Kuwait is excited to be the ... diagnostic option for measuring tear production levels to aid in ... is a revolutionary new testing method for dry eyes. Using ... tears a patient produces and take the necessary steps to ... the Kuwait medical center. “The test collects a small amount ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 Studies find that ... health. Juice cleanses offer clearer skin, more energy, refresh the ... Pearl Recovery Retreat, a wellness center in Beverly Hills, is ... from the comfort of their recovery room. , “It’s important ... them well again following surgery in our Los Angeles ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 Denver ... Inspirational Sponsor for the American Lung Association in Colorado’s ... thrilled to welcome Webolutions as a sponsor,” said Curt ... Southwest, and Executive Director, American Lung Association in Colorado, ... the table in this role they’ve defined.” , Webolutions ...
Breaking Medicine News(10 mins):Health News:Recently Featured in Current Pedorthics: Bunion Bootie, the Very Popular Bunion Treatment Splint 2Health News:Recently Featured in Current Pedorthics: Bunion Bootie, the Very Popular Bunion Treatment Splint 3Health News:Study Suggests Environmental Factors May Outweigh Genetics When It Comes to Myopia 2Health News:Beverly Hills Kuwait is the First Medical Center in Kuwait with Access to TearLab 2Health News:Los Angeles Surgery Recovery Center Now Offering Juice Cleanses 2Health News:Los Angeles Surgery Recovery Center Now Offering Juice Cleanses 3Health News:Denver Marketing Agency Webolutions Named Inspirational Sponsor for 2014 Run the ‘Rocks 5K 2Health News:Denver Marketing Agency Webolutions Named Inspirational Sponsor for 2014 Run the ‘Rocks 5K 3
... as the Best in GI and Endoscopy Nursing at ... Society of Gastroenterology Nurses and Associates, Inc. (SGNA) is ... series of annual awards that recognize their dedication to ... of these four distinguished awards represent the best in ...
... Calif., May 15 ChromaDex Corporation, (OTC Bulletin ... and contract research, today announced financial results for ... calculated in accordance with U.S. Generally Accepted Accounting ... attributable to common stockholders of $0.01 per share ...
... Cimzia(R) (certolizumab pegol) now offered in an innovative ... GRIPS(R)ATLANTA, May 15 - UCB today announced that ... Necrosis Factor) approved in the U.S. for reducing ... clinical response in adult patients with moderate to ...
... it has been known that aspirin is beneficial to ... of the many different types of aspirin is likely ... led by Dr. Sean Nordt from the University of ... to a group of volunteer research subjects: regular aspirin ...
... May 15 Endocare, Inc. (Nasdaq: ENDO ... development of minimally invasive technologies used by urologists and ... results for the first quarter ended March 31, 2009. ... increase in revenue and strong margins.Total revenues for the ...
... Bruno E. Gerber is recognized in Continental Who,s ... Consultant Orthopedic Surgeon with a special interest in ... lower limbs. He also is employed as medical ... regarding innovative orthopedic laser treatment.Dr. Gerber undertook his ...
Cached Medicine News:Health News:SGNA Honors Outstanding Gastroenterology and Endoscopy Professionals With Nationwide Awards 2Health News:SGNA Honors Outstanding Gastroenterology and Endoscopy Professionals With Nationwide Awards 3Health News:SGNA Honors Outstanding Gastroenterology and Endoscopy Professionals With Nationwide Awards 4Health News:ChromaDex Reports 2009 Q1 Financial Results 2Health News:ChromaDex Reports 2009 Q1 Financial Results 3Health News:Cimzia(R) (certolizumab pegol) Now Available for Self-Administration in Adult Patients With Moderate to Severe Crohn's Disease 2Health News:Cimzia(R) (certolizumab pegol) Now Available for Self-Administration in Adult Patients With Moderate to Severe Crohn's Disease 3Health News:Cimzia(R) (certolizumab pegol) Now Available for Self-Administration in Adult Patients With Moderate to Severe Crohn's Disease 4Health News:Cimzia(R) (certolizumab pegol) Now Available for Self-Administration in Adult Patients With Moderate to Severe Crohn's Disease 5Health News:Cimzia(R) (certolizumab pegol) Now Available for Self-Administration in Adult Patients With Moderate to Severe Crohn's Disease 6Health News:Cimzia(R) (certolizumab pegol) Now Available for Self-Administration in Adult Patients With Moderate to Severe Crohn's Disease 7Health News:Cimzia(R) (certolizumab pegol) Now Available for Self-Administration in Adult Patients With Moderate to Severe Crohn's Disease 8Health News:Cimzia(R) (certolizumab pegol) Now Available for Self-Administration in Adult Patients With Moderate to Severe Crohn's Disease 9Health News:Cimzia(R) (certolizumab pegol) Now Available for Self-Administration in Adult Patients With Moderate to Severe Crohn's Disease 10Health News:Endocare Reports 2009 First Quarter Financial Results 2Health News:Endocare Reports 2009 First Quarter Financial Results 3Health News:Endocare Reports 2009 First Quarter Financial Results 4Health News:Endocare Reports 2009 First Quarter Financial Results 5Health News:Endocare Reports 2009 First Quarter Financial Results 6Health News:Endocare Reports 2009 First Quarter Financial Results 7Health News:Endocare Reports 2009 First Quarter Financial Results 8Health News:Endocare Reports 2009 First Quarter Financial Results 9Health News:Endocare Reports 2009 First Quarter Financial Results 10Health News:Endocare Reports 2009 First Quarter Financial Results 11Health News:Continental Who's Who Executive Press Release: Dr. Bruno E. Gerber - Medical Professional 2
(Date:8/20/2014)... -- Research and Markets  has announced the addition of ... their offering. Global Market Report of Pralmorelin ... and regionally ( Europe , Asia ... Latin America etc.). It captures Pralmorelin market trends, ... on three primary areas; manufacture methods & technology development, market ...
(Date:8/20/2014)... Ariz. , Aug. 20, 2014   ... the  Roche  Group, today announced that its VENTANA ... CE marked in the European Union for routine ... The system, consisting of VENTANA Virtuoso software coupled ... VENTANA iScan HT slide scanner, provides automated digital ...
(Date:8/20/2014)... PHOENIX , Aug. 20, 2014 /PRNewswire-USNewswire/ ... next-generation sequencing and proteomic diagnostics and biomarker driven ... collaboration with TESARO, Inc.  Paradigm will use its ... from clinical trials to better predict which patients ... may lead to more successful clinical trial outcomes ...
Breaking Medicine Technology:Global Market Report of Pralmorelin 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2
... The BiPAP Pro with Bi-Flex bi-level system, ... that the BiPAP Pro takes to change ... Digital Auto-Trak Sensitivity™ which automatically triggers the ... pressures based on the patients breathing rhythm. ...
... Electrophoresis System (PGGE) is designed to ... density lipoproteins (LDL) and high density ... using nondenaturing pore gradient gel electrophoresis. ... short DNA sequencing runs. Temperature control ...
This control is intended for monitoring cell counts in patient cerebrospinal fluid samples, performed manually using a hemocytometer. Spinalscopics is fortified to target levels with purified chemica...
... Suitable for use with Leica ... bilirubinometers (pediatric) and all automated ... including Aeroset, AU Series, Cobas, ... These controls contain purified bilirubin ...
Medicine Products: